Dingdang Health Technology Group

Dingdang Health Technology Group EBIT per Share

The EBIT per Share of Dingdang Health Technology Group (9886.HK) as of Nov 2, 2026 is -0.05 CNY. In the previous year, EBIT per Share was -0.16 CNY — a change of -70.47% (higher).

EBIT per Share

-0.05CNY

YoY

-70.47%

Last updated:

EBIT per Share of Dingdang Health Technology Group is 2025 -0.05 CNY. EBIT per Share of Dingdang Health Technology Group was 2024 -0.16 CNY. It decreases by -70.47% higher compared to the previous year.

The Dingdang Health Technology Group EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2020
-0.64 CNY
Jan 1, 2021
-0.83 CNY
Jan 1, 2022
-0.31 CNY
Jan 1, 2023
-0.21 CNY
Jan 1, 2024
-0.16 CNY
Jan 1, 2025
-0.05 CNY
Jan 1, 2026 (e)
0.02 CNY
Jan 1, 2027 (e)
0.00 CNY
The Dingdang Health Technology Group EBIT per Share history
YEAREBIT per ShareYoY
est0.00CNY-100.00%
est0.02CNY-132.72%
-0.05CNY-70.47%
-0.16CNY-21.87%
-0.21CNY-32.92%
-0.31CNY-62.49%
-0.83CNY+29.49%
-0.64CNY+39.44%
-0.46CNY+72.18%
-0.27CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dingdang Health Technology Group Stock analysis

What does Dingdang Health Technology Group do? Dingdang Health Technology Group Ltd. generates revenue through its Pharmaceutical and Healthcare Business segment, which offers online direct sales, business distribution, offline smart pharmacies, express delivery services, and online medical consultation. The company also earns income from the Others segment, providing marketing services, marketplace services, and other services. Its primary customers are domestic consumers and businesses within China, leveraging its domestic market focus. The firm operates two distinct business segments to serve the pharmaceutical and healthcare needs of its target market. The company's Pharmaceutical and Healthcare Business segment focuses on delivering healthcare solutions through multiple channels, including online platforms and physical smart pharmacies, while the Others segment supports these operations with complementary services like marketing and marketplace solutions. Both segments operate exclusively within the domestic market, targeting Chinese consumers and businesses seeking pharmaceutical and healthcare services. Dingdang Health Technology Group Ltd. utilizes its two business segments to maximize revenue streams from domestic healthcare service delivery. Revenue is derived from the direct sale of pharmaceutical products, distribution services, and healthcare-related online consultations, alongside marketing and marketplace services provided to other businesses. The company’s domestic market strategy ensures that all services and products are tailored to meet the needs of Chinese consumers and businesses, with no international operations. Its business model relies on the integration of online and offline services to enhance customer experience and drive sales. Dingdang Health Technology Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dingdang Health Technology Group stock

EBIT per Share of Dingdang Health Technology Group is -0.05 CNY in 2025.

EBIT per Share of Dingdang Health Technology Group changed from -0.16 CNY to -0.05 CNY, representing a -70.47% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Dingdang Health Technology Group since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Dingdang Health Technology Group

All Key Metrics — Dingdang Health Technology Group